In this model, the high-LPCAT2 cancer cell phenotype under anticancer agent treatments such as the FOX regimen, produces more LDs to maintain ER homeostasis, sequester CRT and impair ICD (Fig. 10). This evidence concerns the gene LPCAT2 and cancer.